In this review, the authors present recent findings that uncover a previously unappreciated nuclear signaling hub: the PIPn-p53 signalosome. This complex not only modulates AKT activation within the nucleus but also integrates two major oncogenic pathways—p53 dysregulation and PI3K-AKT amplification—into a unified mechanism driving cancer cell migration and invasion.
Key points of the review include:
This review highlights the nuclear PIPn-p53 signalosome as a central regulator of cancer cell motility and a promising target for metastasis therapy. The work entitled “The Nuclear Phosphoinositide-p53 Signalosome in the Regulation of Cell Motility” was published in Protein & Cell (Advance access May 26, 2025).
Protein & Cell
Systematic review
Not applicable
The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility
26-May-2025